Bettina S. Nedergaard

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers et al. · JAMA · 2014 · 501 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

Paul D. Miller, Nicola Pannacciulli, Jacques P. Brown et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 234 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer

Andreas Carus, Morten Ladekarl, Henrik Hager et al. · British Journal of Cancer · 2013 · 131 citations · Full text

Medicine, Oncology, Pathology +17

A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years

Bettina S. Nedergaard, Morten Ladekarl, Jens Randel Nyengaard et al. · Gynecologic Oncology · 2007 · 118 citations

Medicine, Immunology, Oncology +15